Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation. 1996

M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Boston, MA 02111, USA.

Natural killer (NK) cell activity has been postulated to be an immunologic link between beta-carotene and cancer prevention. In a cross-sectional, placebo-controlled, double-blind study we examined the effect of 10-12 y of beta-carotene supplementation (50 mg on alternate days) on NK cell activity in 59 (38 middle-aged men, 51-64 y; 21 elderly men, 65-86 y) Boston area participants in the Physicians' Health Study. No significant difference was seen in NK cell activity due to beta-carotene supplementation in the middle-aged group. The elderly men had significantly lower NK cell activity than the middle-aged men; however, there was no age-associated difference in NK cell activity in men supplemented with beta-carotene. beta-carotene-supplemented elderly men had significantly greater NK cell activity than elderly men receiving placebo. The reason for this is unknown; however, it was not due to an increase in the percentage of NK cells, nor to an increase in interleukin 2 (IL-2) receptor expression, nor to IL-2 production. beta-carotene may be acting directly on one or more of the lytic stages of NK cell cytotoxicity, or on NK cell activity-enhancing cytokines other than IL-2, such as IL-12. Our results show that long-term beta-carotene supplementation enhances NK cell activity in elderly men, which may be beneficial for viral and tumoral surveillance.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005527 Food, Fortified Any food that has been supplemented with essential NUTRIENTS either in quantities that are greater than those normally present, or which are not found in the food typically. Fortified food also includes food enriched by adding various nutrients to compensate for those removed by refinement or processing. (Modified from Segen, Dictionary of Modern Medicine, 1992). Enriched Food,Food, Supplemented,Enriched Foods,Food, Enriched,Foods, Enriched,Foods, Fortified,Foods, Supplemented,Fortified Food,Fortified Foods,Supplemented Food,Supplemented Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
January 1997, In vivo (Athens, Greece),
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
April 1996, Aging (Milan, Italy),
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
January 2000, International journal of food sciences and nutrition,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
January 1997, Anticancer research,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
December 2001, Experimental gerontology,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
July 1983, Infection and immunity,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
January 1992, Life sciences,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
February 1985, The Journal of parasitology,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
January 1989, Japanese journal of medicine,
M S Santos, and S N Meydani, and L Leka, and D Wu, and N Fotouhi, and M Meydani, and C H Hennekens, and J M Gaziano
June 1993, Brain, behavior, and immunity,
Copied contents to your clipboard!